$36.34
0.010.03%
Últ. Act.: Oct 22, 1:43 PM
$36.40
0.070.19%
Pacira BioSciences (PCRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pacira BioSciences (PCRX) publicó su última previsión de agosto 4, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $735M - $760M para el período.
En comparación con la previsión anterior, Pacira BioSciences reducido redujo su previsión de ingresos desde un rango anterior de $745M - $770M.
Pacira BioSciences ha emitido 16 actualizaciones de orientación entre el enero 5, 2023 y el agosto 4, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.57 | $0.52 | $0.78 | $0.56 |
| Actual | $0.73 | $0.60 | $0.57 | $0.70 |
| Surprise | +28.1% | +15.4% | -26.9% | +25.0% |
| Revenue | ||||
| Estimate | $190.9M | $173.9M | $200.0M | $182.4M |
| Actual | $192.4M | $177.4M | $196.9M | $179.5M |
| Surprise | +0.79% | +1.97% | -1.54% | -1.57% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.68 | $0.78 | $0.41 | $0.42 |
| Revenue | ||||
| Consensus | $183.0M | $201.9M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.73 | $0.57 | 28.1 % |
| Q1 | Apr 30, 2026 | $0.60 | $0.52 | 15.4 % |
| Q4 | Feb 26, 2026 | $0.57 | $0.78 | -26.9 % |
| Q3 | Nov 6, 2025 | $0.70 | $0.56 | 25.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $192.40M | $190.89M | 0.79 % |
| Q1 | Apr 30, 2026 | $177.38M | $173.95M | 1.97 % |
| Q4 | Feb 26, 2026 | $196.87M | $199.95M | -1.54 % |
| Q3 | Nov 6, 2025 | $179.52M | $182.38M | -1.57 % |